Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
29.19
-0.71 (-2.37%)
Sep 4, 2026, 4:00 PM EDT - Market closed
Zymeworks Market Cap
Zymeworks has a market cap or net worth of $2.07 billion as of September 4, 2026. Its market cap has increased by 94.87% in one year.
Market Cap
2.07B
Enterprise Value
1.76B
1-Year Change
94.87%
Ranking
Category
Stock Price
$29.19
ChartMarket Cap Chart
Since April 28, 2017, Zymeworks's market cap has increased from $329.40M to $2.07B, an increase of 528.81%. That is a compound annual growth rate of 21.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 2.07B | 5.12% |
| Dec 31, 2025 | 1.97B | 95.40% |
| Dec 31, 2024 | 1.01B | 38.65% |
| Dec 29, 2023 | 727.30M | 46.87% |
| Dec 30, 2022 | 495.20M | -35.10% |
| Dec 31, 2021 | 763.00M | -64.77% |
| Dec 31, 2020 | 2.17B | 20.97% |
| Dec 31, 2019 | 1.79B | 281.53% |
| Dec 31, 2018 | 469.30M | 143.92% |
| Dec 29, 2017 | 192.40M | -41.59% |
| Apr 28, 2017 | 329.40M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| UroGen Pharma | 2.16B |
| ADMA Biologics | 2.15B |
| Zenas BioPharma | 2.14B |
| Aurinia Pharmaceuticals | 2.14B |
| Kailera Therapeutics | 2.10B |
| Generate Biomedicines | 2.10B |
| Hemab Therapeutics Holdings | 2.07B |
| Vericel | 2.06B |